Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7990

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

A line chart showing percent maintained over a 6-month period for Esomeprazole Magnesium in 10 mg, 20 mg, and 40 mg doses compared to a placebo. The horizontal axis represents months with scheduled visits indicated, and the vertical axis shows percent maintained from 0 to 100. Different line styles and markers distinguish each dose and placebo groups.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

A line graph depicting the percentage maintained over six months for Esomeprazole Magnesium at 40 mg, 20 mg, 10 mg doses, and placebo. The x-axis shows months with scheduled visits (S), and the y-axis shows percent maintained, with higher doses maintaining near 100% and placebo declining to about 30% by month 6.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The 40 mg and 20 mg groups show higher symptom-free percentages over time compared to placebo, which remains consistently lower.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph depicting the percent of patients symptom-free over 28 diary days. It compares Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo groups, showing the symptom-free percentage on the vertical axis and diary days on the horizontal axis.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of Esomeprazole Magnesium, depicted as two molecular units with methoxy, methyl, and sulfoxide functional groups, complexed with magnesium ion and three water molecules.*

FDA Label Image

Label Image (Lbl500907990)

Packaging label for Esomeprazole Magnesium delayed-release capsules, USP 20 mg, from A-S Medication Solutions. The label includes drug name, strength (20 mg), dosage form (capsule delayed release), route (oral), and a quantity of 30 capsules per bottle. The label also shows an NDC (50090-7990) and usage designation RX ONLY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.